11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SELL-SHORT"for Genzyme Corporati (NASDAQ:GENZ) Stock.
GENZ stock opening price was $53.06 per share.
Current price of NASDAQ:GENZ Stock is $49.28 per share
and it is
$-3.89, (-7.32%) today
and it was trading in the daily range of $47.80 - 53.99 per share.
Current Bid Price for (NASDAQ:GENZ) stock is $49.05 and the Ask Price is $49.39. In the last 52 weeks
GENZ stock was trading in the range of $47.09 - 73.75. 50-Day Moving Average for (NASDAQ:GENZ) stock is
$54.0505 and 200-Day Moving Average is $55.1408. On average analysts predict that One Year Target Estimated price for
(NASDAQ:GENZ) stock is $59.78.
Genzyme Corporati (NASDAQ:GENZ)Market capitalization is $13.078B. (NASDAQ:GENZ) stock average daily volume is
3,329,350 shares per day.
However, on last trading session of Nov 13, 2009
GENZ stock traded 27,982,142 shares.
Also The Short Ratio for (NASDAQ:GENZ) stock is 1.40.
On previous trading session GENZ Stock closed at $53.17 per share.
Last year Genzyme Corporati (NASDAQ:GENZ) before taxes (EBITDA) (ttm) earned $1.631B on total revenue of $4.608B.
Earnings Per Share - EPS (ttm) for GENZ stock is 1.754.
Also, (NASDAQ:GENZ) Stock Price Per Earnings ratio - P/E is 30.31.
Thus, (NASDAQ:GENZ) Stock Price/Sales (ttm) ratio is 3.06 and Price/Book (mrq) ratio is 1.85.
(NASDAQ:GENZ) Stock does NOT PAY any dividend.
So at this time (NASDAQ:GENZ) Stock maintains Trailing Annual Dividend Rate at 0.00
.
StockRing Recommendations for Genzyme Corporati (NASDAQ:GENZ) Stock are updated daily here
Genzyme Corporation (NasdaqGS: GENZ) Company Information
Genzyme Corp.
500 Kendall Street
Cambridge, MA 02142
United States - Map
Phone: 617-252-7500
Fax: 617-252-7600
Web Site: http://www.genzyme.com
Genzyme Corporation (NasdaqGS: GENZ) DETAILS
Genzyme Corporation (NasdaqGS: GENZ) Index Membership: S&P 500
S&P 1500 Super Comp
Nasdaq 100
Genzyme Corporation (NasdaqGS: GENZ) Sector: Healthcare
Genzyme Corporation (NasdaqGS: GENZ) Industry: Biotechnology
Genzyme Corporation (NasdaqGS: GENZ) Full Time Employees: 11,000
Genzyme Corporation (NasdaqGS: GENZ) BUSINESS SUMMARY
Genzyme Corporation operates as a biotechnology company worldwide. The company?s Genetic Diseases segment manufactures and distributes therapeutic products, including Cerezyme as an enzyme replacement therapy for the treatment of Type 1 and Type 3 Gaucher diseases; Fabrazyme, a recombinant form of the human enzyme alpha- galactosidase for the treatment of Fabry disease; Myozyme as a therapy for Pompe disease; and Aldurazyme for the treatment of Mucopolysaccharidosis I. This segment markets and sells its products directly to physicians, hospitals, treatment centers, pharmacies, and government agencies through distributors. Its Cardiometabolic and Renal segment develops, manufactures, and distributes products consisting of Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol, a line of vitamin D2 pro-hormone products for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. This segment sells its products to retail pharmacies, hospitals, and other providers of medication to patients. The company?s Biosurgery segment provides biotherapeutics and biomaterial-based products, which comprise Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, which include Campath for the treatment of B-cell chronic lymphocytic leukemia; Clolar for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia; and Mozobil for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. The company was founded in 1981 and is based in Cambridge, Massachusetts.
Genzyme Corporation (NasdaqGS: GENZ) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Henri A. Termeer , Age: 62
Exec. Chairman, Chief Exec. Officer and Pres Salary: $ 3.54M Bonus: $ 0
Mr. Michael S. Wyzga , Age: 53
Chief Financial Officer and Exec. VP of Fin. Salary: $ 999.00K Bonus: $ 1.36M
Mr. Sandford D. Smith , Age: 61
Pres of International Group Salary: $ 979.00K Bonus: $ 711.00K
Mr. Earl M. Collier Jr., Age: 61
Exec. VP Salary: $ 1.05M Bonus: $ 3.54M
Mr. Peter Wirth Esq., Age: 58
Exec. VP of Corp. Devel., Exec. VP of Legal and Sec. Salary: $ 1.22M Bonus: $ 0
By David O'Brien The major indexes closed the week on a winning note, making up most of Thursday's losses. The Dow closed up 0.7%, the S&P 500 added 0.6% and the Nasdaq gained 0.9%. The teen ...
(Source: Associated Press/AP Online) Weak dollar no quick fix for narrowing trade gap WASHINGTON (AP) - A weaker dollar may boost the nation's economy by increasing exports and narrowing the trade ...
NEW YORK — The following stocks were among those that moved substantially or traded heavily Friday on the New York Stock Exchange: NYSE: JC Penney Co., up $1.82 at $31.21 The department ...
This was one of those low-volume trading days where more stocks were up than down with the big explanation being "fewer sellers than buyers." Commodity import prices, the trade deficit, and a weak ...
Terra Industries (TRA) implied volatility is moving higher amid activity call buying Friday. Shares are up $1.02 to $36.22 and 11,900 call options had traded by midday, which represents 2.5X the ...
by Andrew Wilkinson GENZ- Genzyme Corp. – A hot topic in the last few minutes has seen shares of biotech company, Genzyme slide by 5% to $50.50 with the AP reporting that the FDA has found tiny ...
HOTTREND LIST OF MOST ABNORMALLY TRADED STOCKS DATE: 11/13/2009 COUNTRY: US EXCHANGE: NASDAQ TIME PREIOD: 9:30 - 3:30 LAST CHANGE %CHANGE RANK COMPANY NAME TICKER PRICE ON DAY ON DAY 1 NETLIST INC ...
Shire Pharmaceuticals (Nasdaq: SHPGY), a specialty pharmaceutical company, is recently up $2.42 to $58.97 as Genzyme (Nasdaq: GENZ) sells ... StreetInsider.com provides up-to-the-minute active ...
Table of Unusual NASDAQ Stock Moves From Townsend Analytics Wall Street Journal Each stock has a constantly updated profile based on measures like price change, volume, money flow and others. A stock becomes "abnormal" when it deviates ...
NASDAQ:GENZ, ISIS, OSIP - Top Biotech Stocks - Stock Alert TransWorldNews (press release) Genzyme Corporation (NASDAQ:GENZ) surges 2.16% or $1.11 to $52.54 on a massive volume of 2.14 million shares after yesterday it lowered its fiscal 2009 ...
About this author: Seeking Alpha (blog) Genzyme (GENZ) is seeing 9X average trading volume, with 73000 contracts traded and call volume representing 51 percent of today's trading activity. ...
By: Zacks Equity Research Zacks.com Revenues in the reported quarter included the recognition of $10 million in revenue under the company's agreement with Genzyme Corporation (GENZ - Analyst ...
Stocks erase gains in final hour as Bove cuts Wells Fargo San Diego Daily Transcript (subscription) (Nasdaq: GENZ) declined 6.2 percent to $51.43. The world's largest maker of drugs for rare genetic disorders reported third-quarter profit excluding some ...
By: Zacks Equity Research Zacks.com Collaboration partner Genzyme (GENZ - Analyst Report) intends to file the first new drug application (NDA) for mipomersen in the US for homozygous familial ...
BTG 1H Pretax Profit Down 25%; Eyeing Drug Buys Wall Street Journal (GENZ) is testing leukemia medicine Campath in multiple sclerosis patients, while AstraZeneca PLC (AZN.LN) is due to start a Phase II trial of sepsis ...
Stocks rise to extend market's second straight weekly gain San Diego Daily Transcript (subscription) (Nasdaq: GENZ) dropped 7.3 percent to $49.28 for the biggest decline in the S&P 500. US regulators said some lots of the company's Cerezyme, Fabrazyme, ...
12/7/2008 StockRing advise: SELL 33% or 163, HOLD 47% or 237, BUY ...GENZ, HOLD - Genzyme Corporation (NasdaqNM : GENZ), Dec 5, 65.53, +4.32, +7.06%, 3697165. 195. GILD, HOLD - Gilead Sciences, Inc. (NasdaqNM : GILD), Dec 5, 47.39, +1.84, +4.04%, 11575311. 196. GIS, HOLD - General Mills, Inc. ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ...
12/25/2008 stockring advise: sell 35% or 176, hold 39% or 195, buy ...genz, hold - genzyme corporation (nasdaqnm : genz), dec 24, 66.22, -0.18, -0.27%, 577885. 195. gild, buy - gilead sciences, inc. (nasdaqnm : gild), dec 24, 50.46, +0.46, +0.92%, 3002901. 196. gis, super sell - general mills, ...
11/22/2008 stockring buy-sell-hold ratings for s&p 500 stocksgenz, hold - genzyme corporation (nasdaqnm : genz), nov 20, 66.87, -1.13, -1.66%, 4594444. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), nov 20, 41.53, -1.67, -3.87%, 10959634. 196. gis, hold - general mills, ...
12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ...genz, super sell - genzyme corporation (nasdaqnm : genz), 4:00pm, 63.56, +3.52, +5.86%, 4167883. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), 4:00pm, 46.17, +2.08, +4.72%, 11310658. 196. gis, super sell - general mills, ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ...
12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ...genz, super sell - genzyme corporation (nasdaqnm : genz), dec 3, 63.56, +3.52, +5.86%, 4167883. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 3, 46.17, +2.08, +4.72%, 11310658. 196. gis, super sell - general mills, ...
Data and information is provided for informational purposes only, and is not intended
for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any
actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information
found therein.
No comments:
Post a Comment